Atlas Trials

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions

Clinical trial NCT04155203 · COMPLETED

Trial details

NCT number
NCT04155203
Sponsor
Padagis LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondarily Infected Traumatic Skin Lesions
Start date
2019-10-15
Primary completion
2021-06-01
Enrollment
657

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.